Real World Experience of CAR-T in MM Patients

Opinion
Video

This segment examines Dr. Mikhael's approach to comparing ide-cel and cilta-cel for patient selection, emphasizing how patient traits, efficacy, and safety profiles influence treatment decisions across different groups.

Video content above is prompted by the following:

  • How would you assess ide-cel versus cilta-cel when it comes to selecting patients?
  • Are there any patient traits that might steer you toward one CAR-T product over the other?
    • In what ways do the efficacy and safety profiles of these treatments impact your choices for different patient groups?

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
2 experts in this video
2 experts in this video
2 experts are featured in this series.
2 experts are featured in this series.
4 experts in this video
2 experts in this video
Related Content